MX9701187A - Nuevas lactamas naftofusionadas n-substituidas. - Google Patents
Nuevas lactamas naftofusionadas n-substituidas.Info
- Publication number
- MX9701187A MX9701187A MX9701187A MX9701187A MX9701187A MX 9701187 A MX9701187 A MX 9701187A MX 9701187 A MX9701187 A MX 9701187A MX 9701187 A MX9701187 A MX 9701187A MX 9701187 A MX9701187 A MX 9701187A
- Authority
- MX
- Mexico
- Prior art keywords
- growth hormone
- naphthofused
- lactams
- substituted
- novel
- Prior art date
Links
- 150000003951 lactams Chemical class 0.000 title abstract 2
- 102000018997 Growth Hormone Human genes 0.000 abstract 3
- 108010051696 Growth Hormone Proteins 0.000 abstract 3
- 239000000122 growth hormone Substances 0.000 abstract 3
- 150000001875 compounds Chemical class 0.000 abstract 2
- 206010056438 Growth hormone deficiency Diseases 0.000 abstract 1
- 244000144972 livestock Species 0.000 abstract 1
- 230000036470 plasma concentration Effects 0.000 abstract 1
- 230000017363 positive regulation of growth Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 230000028327 secretion Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DK95294 | 1994-08-17 | ||
| PCT/DK1995/000332 WO1996005195A1 (en) | 1994-08-17 | 1995-08-17 | Novel n-substituted naphthofused lactams |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX9701187A true MX9701187A (es) | 1997-05-31 |
Family
ID=8099355
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX9701187A MX9701187A (es) | 1994-08-17 | 1995-08-17 | Nuevas lactamas naftofusionadas n-substituidas. |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US5817654A (enExample) |
| EP (1) | EP0777668A1 (enExample) |
| JP (1) | JPH10504293A (enExample) |
| CN (1) | CN1158127A (enExample) |
| AU (1) | AU697003B2 (enExample) |
| BR (1) | BR9508805A (enExample) |
| CA (1) | CA2196877A1 (enExample) |
| CZ (1) | CZ45897A3 (enExample) |
| HU (1) | HUT76645A (enExample) |
| IL (1) | IL114955A (enExample) |
| MX (1) | MX9701187A (enExample) |
| NO (1) | NO970684L (enExample) |
| PL (1) | PL318633A1 (enExample) |
| TW (1) | TW321640B (enExample) |
| WO (1) | WO1996005195A1 (enExample) |
| ZA (1) | ZA956869B (enExample) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6211174B1 (en) | 1997-10-31 | 2001-04-03 | Merck & Co., Inc. | Naphtho-fused lactams promote release of growth hormone |
| US6380184B1 (en) | 1998-10-28 | 2002-04-30 | Bristol-Myers Squibb Co. | Benzoazepines and analogs thereof useful as growth hormone secretagogues |
| JP2002542151A (ja) | 1999-02-18 | 2002-12-10 | 科研製薬株式会社 | 成長ホルモン分泌促進物質としての新規なアミド誘導体 |
| US6518292B1 (en) | 1999-03-12 | 2003-02-11 | Bristol-Myers Squibb Co. | Heterocyclic aromatic compounds usefuls as growth hormone secretagogues |
| US6525203B1 (en) | 1999-03-12 | 2003-02-25 | Bristol-Myers Squibb Company | Heterocyclic aromatic compounds useful as growth hormone secretagogues |
| CZ20014665A3 (cs) * | 1999-06-30 | 2002-05-15 | Hamilton Civic Hospitals Research Development, Inc | Prostředek s obsahem heparinu se střední molekulovou hmotností |
| ATE310728T1 (de) | 2000-05-11 | 2005-12-15 | Bristol Myers Squibb Co | Tetrahydroisochinolin-analoga als wachstumshormon-sekretagoga |
| US20040038932A1 (en) * | 2000-09-08 | 2004-02-26 | Jack Hirsh | Antithrombotic compositions |
| WO2003041641A2 (en) | 2001-11-09 | 2003-05-22 | Bristol-Myers Squibb Company | Tetrahydroisoquinoline analogs as modulators of chemokine receptor activity |
| WO2013190520A2 (en) | 2012-06-22 | 2013-12-27 | The General Hospital Corporation | Gh-releasing agents in the treatment of vascular stenosis and associated conditions |
| US9119832B2 (en) | 2014-02-05 | 2015-09-01 | The Regents Of The University Of California | Methods of treating mild brain injury |
| WO2017075535A1 (en) | 2015-10-28 | 2017-05-04 | Oxeia Biopharmaceuticals, Inc. | Methods of treating neurodegenerative conditions |
| IL287136B2 (en) | 2016-02-05 | 2023-09-01 | Denali Therapeutics Inc | Receptor inhibitors - interacting with protein kinase 1 |
| JP7208137B2 (ja) | 2016-12-09 | 2023-01-18 | デナリ セラピューティクス インコーポレイテッド | 化合物、組成物および方法 |
| TW202334164A (zh) | 2022-01-12 | 2023-09-01 | 美商戴納立製藥公司 | （Ｓ）－５－苄基－Ｎ－（５－甲基－４－側氧基－２，３，４，５－四氫吡啶並［３，２－ｂ］［１，４］氧氮呯－３－基）－４Ｈ－１，２，４－三唑－３－甲醯胺的晶型 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5206235A (en) * | 1991-03-20 | 1993-04-27 | Merck & Co., Inc. | Benzo-fused lactams that promote the release of growth hormone |
| US5583130A (en) * | 1992-09-25 | 1996-12-10 | Merck & Co., Inc. | Benzo-fused lactams promote release of growth hormone |
-
1995
- 1995-08-16 IL IL11495595A patent/IL114955A/xx active IP Right Grant
- 1995-08-17 AU AU31618/95A patent/AU697003B2/en not_active Ceased
- 1995-08-17 WO PCT/DK1995/000332 patent/WO1996005195A1/en not_active Ceased
- 1995-08-17 EP EP95927662A patent/EP0777668A1/en not_active Ceased
- 1995-08-17 PL PL95318633A patent/PL318633A1/xx unknown
- 1995-08-17 CN CN95195133A patent/CN1158127A/zh active Pending
- 1995-08-17 BR BR9508805A patent/BR9508805A/pt not_active Application Discontinuation
- 1995-08-17 CZ CZ97458A patent/CZ45897A3/cs unknown
- 1995-08-17 ZA ZA956869A patent/ZA956869B/xx unknown
- 1995-08-17 HU HU9701234A patent/HUT76645A/hu unknown
- 1995-08-17 JP JP8506935A patent/JPH10504293A/ja active Pending
- 1995-08-17 CA CA002196877A patent/CA2196877A1/en not_active Abandoned
- 1995-08-17 MX MX9701187A patent/MX9701187A/es unknown
- 1995-09-15 TW TW084109669A patent/TW321640B/zh active
-
1997
- 1997-01-29 US US08/790,133 patent/US5817654A/en not_active Expired - Fee Related
- 1997-02-14 NO NO970684A patent/NO970684L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| ZA956869B (en) | 1996-04-10 |
| PL318633A1 (en) | 1997-06-23 |
| JPH10504293A (ja) | 1998-04-28 |
| NO970684L (no) | 1997-04-17 |
| IL114955A0 (en) | 1995-12-08 |
| BR9508805A (pt) | 1998-01-06 |
| NO970684D0 (no) | 1997-02-14 |
| HUT76645A (en) | 1997-10-28 |
| AU3161895A (en) | 1996-03-07 |
| US5817654A (en) | 1998-10-06 |
| EP0777668A1 (en) | 1997-06-11 |
| AU697003B2 (en) | 1998-09-24 |
| CA2196877A1 (en) | 1996-02-22 |
| CZ45897A3 (en) | 1997-10-15 |
| IL114955A (en) | 1999-12-22 |
| TW321640B (enExample) | 1997-12-01 |
| WO1996005195A1 (en) | 1996-02-22 |
| CN1158127A (zh) | 1997-08-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UA42747C2 (uk) | Похідні пептиду,фармацевтична композиція та спосіб стимулювання секреції гормону росту | |
| MX9701187A (es) | Nuevas lactamas naftofusionadas n-substituidas. | |
| MY106407A (en) | N-(3-hydroxy-4-piperidinyl)(dihydrobenzo-furan, dihydro-2h-benzopyran or dihydro-benzodioxin) carboxamide derivatives. | |
| MX9604378A (es) | Amidas de acido quinolin-2-carboxilico sustituidas, su preparacion y su empleo como medicamentos, asi como productos intermedios. | |
| UA56989C2 (uk) | ФІЗІОЛОГІЧНО АКТИВНИЙ ПЕГ-КОН'ЮГАТ <font face="Symbol">a</font>-ІНТЕРФЕРОНУ, СПОСІБ ЙОГО ОДЕРЖАННЯ, ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ НА ЙОГО ОСНОВІ ТА СПОСІБ ЛІКУВАННЯ АБО ПРОФІЛАКТИКИ ІМУНОМОДУЛЯТОРНИХ ЗАХВОРЮВАНЬ | |
| NZ504026A (en) | Methods for treating hypercoagulable states or acquired protein C deficiency using human-activated protein C | |
| DE3684409D1 (de) | Verwendung von gamma-linolensaeure und verwandten verbindungen zur herstellung eubnes arzneimittels zur behandlung von endometriose. | |
| MY155218A (en) | Small molecules useful in the treatment of inflammatory disease | |
| IL94282A0 (en) | Azaindenes | |
| YU60900A (sh) | Novi kristalni oblici antivirusnog benzimidazolskog jedinjenja | |
| PT804252E (pt) | Agentes queladores metalicos que contem monoaminas diamidas e tiois | |
| DE69427344D1 (de) | Verabreichung von riluzol zur behandlung von neuro-aids | |
| NO20002702L (no) | Tienopyrimidiner | |
| UA35567C2 (uk) | Фармацевтичний препарат для лікування хворих з порушеннями функції коагуляції, спосіб лікування таких хворих, спосіб одержання фармацевтичного препарату | |
| DE69521536D1 (de) | Zusammensetzungen die G-CSF und ein TNF-Bindungsprotein enthalten | |
| AU2284001A (en) | Substituted aminoalkylamide derivatives as antagonists of follicle stimulating hormone | |
| IL126235A (en) | Compounds with growth hormone releasing properties, pharmaceutical compositions comprising them and their use | |
| MY121387A (en) | Imidazo[1,2-a]pyridine derivatives for the treatment of gastrointestinal diseases | |
| MX9805141A (es) | Uso de inhibidores del intercambiador celular na+/h+ (nhe) para la preparacion de un farmaco para estimular la respiracion. | |
| IL141325A0 (en) | Tan-1057 derivatives | |
| NO991734L (no) | Pyrazolinoner for behandling av potensforstyrrelser | |
| MY120530A (en) | Combination preparation for use in dementia | |
| DE69924483D1 (de) | Kombinationstherapie zur behandlung von tumoren | |
| IL126175A (en) | Pharmaceutical compositions containing endothelin antagonists and novel endothelin antagonists | |
| GB9505082D0 (en) | Medicament |